Literature DB >> 8833889

Isolation, characterization, and biologic features of bone marrow endothelial cells.

G Almeida-Porada1, J L Ascensão.   

Abstract

Bone marrow endothelial cells (BMECs) are an integral part of the bone marrow microenvironment and are likely to play an important role in the regulation of hematopoiesis, either by producing growth factors or inhibitory cytokines or by displaying adhesion molecules that can interact with hematopoietic progenitors. In the present study we demonstrate the isolation, propagation, and characterization of BMECs with regard to morphology, growth characteristics, phenotype, and production of cytokines. Furthermore, we report the creation of a cell line with "BMEC-like" characteristics and compare the characteristics of primary BMEC cultures to those of the immortalized cell line. In addition, we demonstrate that BMECs are susceptible to infection by a laboratory strain of human cytomegalovirus (CMV), suggesting that CMV infection of endothelial cells in vivo could potentially play a role in the hematologic abnormalities observed during CMV infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8833889     DOI: 10.1016/s0022-2143(96)80012-6

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  10 in total

1.  Nonlinear model-based estimates of IC(50) for studies involving continuous therapeutic dose-response data.

Authors:  Robert H Lyles; Cliff Poindexter; Angelo Evans; Milton Brown; Carlton R Cooper
Journal:  Contemp Clin Trials       Date:  2008-06-06       Impact factor: 2.226

2.  Plasmodium-falciparum-infected erythrocytes adhere to immortalized human bone marrow endothelial cells.

Authors:  J G Prudhomme; G Almeida-Porada; J L Ascensao; I W Sherman
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998 Jul-Aug       Impact factor: 2.416

3.  Long-term culture of murine bone-marrow-derived endothelial cells.

Authors:  Q R Wang; Y Yan; B H Wang; W M Li; N S Wolf
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-06       Impact factor: 2.416

4.  Soluble perlecan domain I enhances vascular endothelial growth factor-165 activity and receptor phosphorylation in human bone marrow endothelial cells.

Authors:  Arivalagan Muthusamy; Carlton R Cooper; Ronald R Gomes
Journal:  BMC Biochem       Date:  2010-11-03       Impact factor: 4.059

5.  Cell-based assays using calcein acetoxymethyl ester show variation in fluorescence with treatment conditions.

Authors:  Fayth L Miles; Jill E Lynch; Robert A Sikes
Journal:  J Biol Methods       Date:  2015

6.  Tumor necrosis factor-alpha and endothelial cells modulate Notch signaling in the bone marrow microenvironment during inflammation.

Authors:  Luis Fernandez; Sonia Rodriguez; Hui Huang; Angelo Chora; Jacquenilson Fernandes; Christin Mumaw; Eugenia Cruz; Karen Pollok; Filipa Cristina; Joanne E Price; Michael J Ferkowicz; David T Scadden; Matthias Clauss; Angelo A Cardoso; Nadia Carlesso
Journal:  Exp Hematol       Date:  2008-05       Impact factor: 3.084

7.  Perivascular stromal cells as a potential reservoir of human cytomegalovirus.

Authors:  M A Soland; L R Keyes; R Bayne; J Moon; C D Porada; S St Jeor; G Almeida-Porada
Journal:  Am J Transplant       Date:  2014-03-04       Impact factor: 8.086

8.  Panax ginseng modulates cytokines in bone marrow toxicity and myelopoiesis: ginsenoside Rg1 partially supports myelopoiesis.

Authors:  Hanumantha Rao Balaji Raghavendran; Rekha Sathyanath; Jangwoo Shin; Hyeong Keug Kim; Jong Min Han; JungHyo Cho; Chang Gue Son
Journal:  PLoS One       Date:  2012-04-16       Impact factor: 3.240

9.  Invasive characteristics of human prostatic epithelial cells: understanding the metastatic process.

Authors:  C A Hart; M Brown; S Bagley; M Sharrard; N W Clarke
Journal:  Br J Cancer       Date:  2005-02-14       Impact factor: 7.640

10.  Non-canonical EphA2 activation underpins PTEN-mediated metastatic migration and poor clinical outcome in prostate cancer.

Authors:  Ashwin Sachdeva; Claire A Hart; Kyungmin Kim; Thomas Tawadros; Pedro Oliveira; Jonathan Shanks; Mick Brown; Noel Clarke
Journal:  Br J Cancer       Date:  2022-07-22       Impact factor: 9.075

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.